Work

A Phase 1b Dose-Escalation Study of Split-Dose Oprozomib (ONX0912) in Patients with Hematologic Malignancies

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.203.203

Authors: Michael R. Savona, Jesus G. Berdeja, Susan J Lee, Hansen Wong, Ju RueyJiuan Lee, Heidi H. Gillenwater, David S. Siegel

Institutions: Sarah Cannon, Hackensack University Medical Center

Language: English

Topic: Ubiquitin and proteasome pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2554471213

FWCI: 1.155

Cites:

Cited by: 9

Related to: 10